Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 361–420 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

Dana Farber Cancer Institute5 ED5 Edinburgh University5 England5 GSK5 General Hospital5 Health Research Authority5 Health and Care Research Wales5 Heidelberg University Hospital5 Hospital Pharmacy Department5 Institute for Healthcare Improvement5 J Adv Nurs 20255 JAMA Psychiatry5 James Lind Alliance5 KU Leuven5 Leeds Teaching Hospitals5 Leiden University Medical Centre5 Level 1 trauma center5 MESH Registry5 NCT033015065 National Institute for Clinical Excellence5 Oncology5 Oslo University Hospital5 PAIS Index5 PsychINFO5 PubMed Central5 Radboud University Medical Center5 Royal College of Physicians5 Royal Free5 SNIS5 Simon Fraser University5 Sociological Abstracts5 South London and Maudsley NHS Foundation Trust5 St James’s Hospital5 Swedish CArdioPulmonary BioImage Study5 Synaptogenix5 Tikur Anbessa Specialized Hospital5 UN Digital Library5 University Medical Centre Ljubljana5 University of British Columbia5 University of Manitoba5 University of Melbourne5 University of Michigan5 World Health Organisation5 stroke centers5 Arm B4 ESMO4 Arm A4 Caris Life Sciences4 Stryker Neurovascular4 SIT4 ELSA4 HSS4 ESRA4 FDA-approved4 West China Hospital of Sichuan University4 Cass Review4 Cleveland Clinic4 European Kidney Function Consortium4 NHS Tayside4

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 143 of 946

1ISG-002 High stability, high risk: the dual challenge of experience retention versus demographic decline in Estonian hospital pharmacies

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

89.0%

ESHP Estonian Hospital Pharmacists’ Society

… critical priority. The Estonian Hospital Pharmacists’ Society (ESHP) included supporting this sustainability in its 2023-2026 devel…

4CPS-002 Importance of individualising isankizumab treatment in patients with Crohn’s disease

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

86.0%

Abbott Sequier et al.Suleiman et al.risankizumab Crohn’s disease

…ed by Suleiman et al. was implemented using the PKS software by Abbott. Patients receiving risankizumab were selected, and the predict…

4CPS-005 Clinical, economic and organisational impact of a validation tool on parenteral chemotherapy

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

96.5%

Universitair Ziekenhuis Brussel UZ Brussel Anticancer drugs parenteral chemotherapy quality improvement programme

… critical role in detecting and preventing DRPs. Earlier at the Universitair Ziekenhuis Brussel (UZ Brussel) in 2023 a validation was developed to detect DRPs …

4CPS-020 Analysis of ambulatory and hospital treatment of patients with beta blocking agents at the division of paediatrics of tertiary hospital in years 2022 and 2023

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

90.4%

Division of Paediatrics ATC group C07 propranolol metoprolol bisoprolol haemangiomas arterial hypertension arrhythmias congenital malformations of the circulatory system tachycardia

…agents) in both ambulatory and hospital patients treated at the Division of Paediatrics in a tertiary hospital during 2022 and 2023. Patients were incl…

4CPS-065 Comparative efficacy and safety of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors and tricyclic antidepressants in management of depression cancer patients: a systematic review

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

91.7%

PubMed Cochrane Scopus fluoxetine citalopram venlafaxine duloxetine sertraline escitalopram amitriptyline+2 more

…ong cancer patients.Material and Methods A systematic search of PubMed, Scopus, and Cochrane databases was conducted up to 2024. Eligi…

4CPS-091 Correlation between antibiotic consumption and multidrug-resistant bacteria in an orthopaedic institute: a 3-year retrospective study

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

96.1%

orthopaedic institute infectious diseases unit glycylcycline oxazolidinone MDRB carbapenems MRSA fluoroquinolone multidrug-resistant bacteria (MDRB)

…en antibiotic consumption and the evolution of MDRB rates in an orthopaedic institute over a 3-year period.Material and Methods A retrospective study…

4CPS-210 Analysis of suspected digoxin toxicity with a gender perspective

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

93.1%

tertiary hospital digoxin atrial fibrillation heart failure

…ences in digoxin intoxications in the emergency department of a tertiary hospital.Material and Methods Single-centre retrospective study included…

4CPS-240 Biologics in paediatric severe asthma: real-world evidence from a specialised unit in a tertiary paediatric hospital

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

89.5%

PSAU severe paediatric asthma omalizumab tezepelumab dupilumab mepolizumab Severe Asthma Biologic therapies biologic therapy atopic dermatitis

…a and highlight the critical role of hospital pharmacists, in a PSAU, in patient monitoring and support. Further studies should inco…

4CPS-245 Real-world incidence and management of hypothyroidism secondary to apalutamide in patients with prostate cancer

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

89.7%

Mambrino XXI SIGLO Farmis apalutamide Levothyroxine prostate cancer PC

…nt during follow-up. Data were obtained from SIGLO, Farmis, and Mambrino XXI.Results Eighty-five men were included, median age 73 years, (IQ…

4CPS-298 Improving safety and efficiency in cytotoxic compounding through pharmaceutical interventions

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

89.4%

Cytotoxic Production Unit CPU antineoplastic agents Pharmaceutical Interventions antineoplastic preparations

…umenting Drug-Related Problems (DRP) and associated PI within a Cytotoxic Production Unit (CPU), and to evaluate DRP types, PI characteristics, and accep…

4CPS-317 Measuring the administrative impact of a specialist clinical pharmacist at a neonatal intensive care unit of a teaching hospital in Oman using key performance indicators

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

92.0%

Sultan Qaboos University hospital SQUH sirolimus solution injection bumetanide fluconazole palivizumab probiotics

…rect patient care.Material and Methods This study took place at Sultan Qaboos University hospital (SQUH), a tertiary care teaching institution, with a 24-bed NIC…

5PSQ-015 When seizures persist: exploring novel therapeutic options in aicardi syndrome – case report

ejhpharm · abstract · 2026-03-18 · 3 matching annotations

90.8%

Hospital pharmacy Aicardi syndrome vigabatrin perampanel levetiracetam hydrocortisone lamotrigine fenfluramine valproic acid topiramate

…ampanel, and hydrocortisone, with insufficient seizure control. Hospital pharmacy prepared evidence-based reports to justify the off-label use of…